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EFFECT OF QUANTUM DOTS, NOVEL BIOLOGICAL  





The use of Quantum dots (QDs) coated with polymer and functionalized with 
carboxylic acid groups in medical applications are explored. Their water solubility and 
exceptional stability in aqueous environments make them potentially useful for such 
applications as imaging and ligand attachments. However, there are concerns regarding 
the toxic effects of QDs and the minimal dose that can be used without producing any 
detrimental effects to organisms. In this study, QDs coated with the amphiphilic polymer 
coating tri-n-octylphosphine oxide and poly (maleic anhydride-alt-1-tetradecene (TOPO-
PMAT)) which is functionalized with carboxylic acid groups were used to investigate 
their toxic effect in mouse liver cells. The cells were treated with 2 nM, 20 nM and 40 
nM of QDs for a 24 -hour period and assays were performed to determine the effect on 
cell viability, ATP production, mitochondrial membrane potential and reactive oxygen 
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species (ROS) production. The results showed no significant effect on cell viability, ATP 
production and ROS production. However, the mitochondrial membrane potential of cells 
was significantly decreased when treated with 20 nM and 40 nM QDs. The results 
suggest that TOPO-PMAT QDs could be mildly toxic and precaution should be taken if 





















I would like to thank my committee members, Dr. Carin Thomas, Dr. Levente 
Fabry-Asztalos and Dr. Todd Kroll for their support. Also, I would like to thank my 














TABLE OF CONTENTS 
CHAPTER Page 
I     INTRODUCTION ........................................................................................................ 1 
                        Nanoparticles and Their uses……………………………………………...1  
Quantum Dots ..............................................................................................1 
The Chemical Composition of Quantum Dots .............................................2 
Applications of Quantum Dots ....................................................................4 
Potential Toxic Effect of Quantum Dots .....................................................5 
Mechanism Behind Negative Effect ............................................................9 
Mitochondria ..............................................................................................10 
ATP Synthesis ............................................................................................11 
ROS Production .........................................................................................13 
Liver Cells as Models for Quantum Dots Toxicity Studies .......................15 
 
II     METHODS AND MATERIALS .............................................................................. 16 
Cell Culture and Passage ...........................................................................16 
Counting Cells using Hemocytometer and Plating Cells for 
 Experiments ..............................................................................................17 
Treatment of Cells with Quantum Dots .....................................................19 
Cell Viability Assay ...................................................................................19 
Adenosine Triphosphate (ATP) Luminescence Assay ..............................21 
Flow Cytometry .........................................................................................23 
Mitochondrial Membrane Potential Assay ................................................24 
Growing Cells for Fluorescence Microscopy ............................................25 
Intracellular ROS Assay ............................................................................26 
Statistics .....................................................................................................27 
 
III    RESULTS ................................................................................................................. 28 
Cell Viability ..............................................................................................28 
ATP Content in Cells .................................................................................29 
Mitochondrial Membrane Potential Assay Using JC-10 ...........................31 
Reactive Oxygen Species (ROS) Production in Cells ...............................34 
Comparison of Fluorescenceof QDs and JC-10 Dye .................................37 
 
IV   DISCUSSION ............................................................................................................ 40 
vii 
 
TABLE OF CONTENTS (Continued) 
CHAPTER                                                                                                                            Page 
V   CONCLUSION ........................................................................................................... 47 
      REFERENCES ........................................................................................................... 48 
      APPENDICES ............................................................................................................ 52 
Appendix A: Preliminary Data Using C60 .................................................53 
Appendix B: Statstical Analysis ................................................................56 
Appendix C: Flow Cytometry Dot Plots and Histograms for QDs ...........57 
 
  













LIST OF FIGURES 
Figure Page 
1 Diagram of TOPO-PMAT Quantum Dots. ....................................................... 3 
2 Maximum absorbance and emission of TOPO-PMAT Quantum Dots ............ 4 
 
3 A mitochondrion showing inner membrane, outer membrane, 
            intermembrane space, matrix and cristae. ....................................................... 11 
 
4  Electron transport chain and F0F1 ATPase showing oxidative phosphorylation 
and ROS production. ....................................................................................... 13 
 
5 Glass Hemocytometer diagram showing square spaces used in  
counting cells. ................................................................................................. 18 
 
6 WST-8 reduction reaction in presence and absence of dehydrogenase.. ........ 21 
 
7 Reaction of luciferin and ATP in presence of luciferase. ............................... 23 
8 TBHP reaction with ferrous ion to produce hydroxyl 
 radical, •OH. .................................................................................................. 27 
 
9 Cell viability in liver cells after 24-hr exposure to QDs.. ............................... 29 
 
10 ATP production in liver cells after 24-hr exposure to QDs ............................ 30 
 
11 Fluorescence microscopy images of localization of JC-10 dye 
 in Hepa-V cells. ............................................................................................. 32 
 
12 Mitochondrial membrane potential in liver cells after 24-hr exposure 
 to QDs.. .......................................................................................................... 33 
 
13 Production of reactive oxygen species (ROS) in liver  
cells after 24-hr exposure to QDs ................................................................... 36 
 
14 Median fluorescence intensity of Quantum dots (Panel A) 
 and JC-10 (Panel B) in FL2 (left) and FL3 (Right). ...................................... 38 
 
A1       Cell viability after 24-hr exposure to C60 ........................................................ 53 
 
A2       ATP production in liver cells after 24-hr exposure to C60 .............................. 54 
ix 
 
TABLE OF CONTENTS (Continued) 
Figure Page 
A3       Mitochondrial membrane potential in liver cells after 24-hr exposure 
            to C60 ............................................................................................................... 55 
 
A4       Flow cytometry dot plots and histogram showing gating and median 
fluorescence intensity at FL2 for mitochondrial membrane  
            potential using JC-10 dye................................................................................ 57 
 
      A5       Flow cytometry dot plots and histogram showing gating and median 





Nanoparticles and Their Uses 
Nanoscience is the study and application of extremely small materials that can 
range from 1-100 nm in size.1 The use of nanotechnology in medicine is spreading 
rapidly as a lot of biological events take place in nanoscale; for example, a strand of 
DNA is only about 2 nm in diameter, and hemoglobin, an oxygen carrying protein, is 5.5 
nm in diameter. Engineered nanoparticles are explored for their possible use in drug 
delivery and cancer imaging and therapy. Due to their small size (1-100 nm) and 
relatively large functional surface area, these particles are able to bind, adsorb and carry 
other compounds such as drugs, antibodies and chemical fluorescence probes, and deliver 
them to targets in the body.2 The main reason to use these nanoparticles in drug delivery 
is to decrease the side effects and toxicity of drugs used in the treatments.2 Although 
these nanoparticles can be very useful for different purposes in medicine, there have been 
concerns that these nanoparticles could be toxic to the human biological system and may 
have detrimental effects on human body parts ranging from cell function to organ 
function such as lungs, brain and heart.2 
Quantum Dots 
 There are several nanoparticles available such as nanotubes, nanowires, fullerenes 
and quantum dots (QDs). Among several nanoparticles, we are interested in QDs as they 
are fully described in terms of their chemical compositions and can be used for various 
medical applications.3 QDs used in this study are highly stable in aqueous environments.4 
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Due to their high stability in aqueous environments they are very useful for biological 
imaging and the carboxyl functional group in the coating makes it convenient for ligand 
attachment for use in targeting specific cancers or cells.5 There are various uses of QDs in 
photovoltaic cells, drug delivery, cancer imaging and as different biochemical probes.  
Similarly, further research has shown their promising use for in vivo applications by 
directing antibodies to cancer cell surface receptors and for siRNA delivery.6  
The Chemical Composition of Quantum Dots 
The chemical composition of QDs can be customized according to their uses. 
They usually consist of three parts: a core, a shell and a coating.  There are several 
different types of cores, shells and coatings that can be customized according to the 
application. QDs have an inorganic semi-conductor core that determines their optical 
properties. The core of QDs are mostly composed of elements from groups III and V, 
such as InAs or GaN or groups IIB & VI, such as CdSe, CdS, CdTe, ZnSe, ZnS or ZnTe. 
The QDs whose cores are composed of elements from groups IIB and VI such as CdSe 
and CdS of periodic table emit visible light and are developed for biomedical purposes 
like diagnosis and cancer therapy. The shells in QDs are commonly composed of ZnSe, 
ZnS or CdS.  Similarly, the QDs can be coated with various compounds depending upon 
their application, such as SiO2, polymers and other molecules such as TOPO (tri-n-
octylphosphine oxide). Also, they are often attached to biomolecules such as RNA, DNA, 
protein and lipids that are used to label cells or tissues, enter inside cells or deliver drugs 
to specific organs in the body.  The physical properties of QDs such as solubility, charge, 
efficiency of optical emission and toxicity can be affected by its coating.7  
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 In this study we are using TOPO-PMAT QDs provided by our collaborators at the 
University of Washington. The TOPO-PMAT QDs are made up of a CdSe core, a ZnS 
shell which are surrounded by a TOPO (tri-n-octylphosphine oxide), and a PMAT (poly 
(maleic anhydride-alt-1-tetradecene)) polymer coating (Figure 1). The intermolecular 
force that holds TOPO and PMAT are hydrophobic interactions. The hydrophobic 
interaction between TOPO and PMAT makes it very stable in aqueous solution which 
makes it very useful for medical purposes. The absorbance spectrum of these TOPO- 
PMAT QDs was determined to be between 400 nm to 500 nm and the fluorescence 
spectrum showed the maximum fluorescence emission at 620 nm (Figure 2).8 
 






Figure 2: Maximum absorbance and emission of TOPO-PMAT Quantum Dots.8 
 
Applications of Quantum Dots  
 TOPO-PMAT quantum dots are useful for biological imaging because of their 
high water solubility due to the carboxylic group attached to the outside and exceptional 
stability. These QDs can be used for molecular markers in cells instead of organic dyes 
and antibodies. Mortalin, a member of hsp 70 protein family which is a marker of 
transformed and normal cells depending upon its staining pattern can be stained easily 
with fluorescing quantum dots which otherwise requires several steps of staining with 
primary and secondary antibodies.9 Kaul and colleagues showed that the mortalin 
staining pattern was uniform in cytoplasm and the perinuclear (space between the inner 
and outer layer of nucleus) in transformed (osteocarcinoma, U2OS) cells as reported 
previously by using the organic fluorescent dyes.9 In addition, staining with QDs also 
provides longer fluorescence time. Mortalin stained with the organic dye “Alexa probe” 
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fades away after 3 minutes whereas the mortalin stained with QDs remained for 8 
minutes giving longer and more accurate visualization.  
Similarly, the presence of carboxyl functional groups in the coating of these QDs 
make them useful for ligand attachment. These kind of QDs can be modified accordingly 
for tumor targeting in vivo using antibodies directed to ligand surface receptors on cancer 
cells. Yang and colleagues coupled antibody (ScFvEGFR) with QDs to deliver the 
epidermal growth factor receptor (EGFR) in epidermal growth factor (EGF) expressing 
tumor in vivo mice models via tail vein. The result showed that there were large amounts 
of QDs bound to tumor cells in sections taken from frozen tumor tissues.10 This shows 
that the QDs can be modified to target the tumor cells. Likewise, QDs can also be used 
for SiRNA delivery. SiRNA can be used in knocking down any type of mRNA which can 
be very useful in genomic studies and treatment of some tough diseases such as cancer. 
However, the delivery of siRNA in vivo is very difficult in practice which can be solved 
using QDs as a delivery vehicle. At least 50 copies of SiRNA were delivered to the 
targeted site by using TOPO-QDs in rats with xenograft prostrate tumors.11 There are 
many probable applications of quantum dots in medical fields, and research is ongoing on 
the use of QDs in medical applications. However, there are concerns regarding the toxic 
effect of QDs when used for medical purposes.  
 
Potential Toxic Effect of Quantum Dots  
Despite their usefulness, concerns have been raised about QDs’ potential toxic 
effects in organisms. There are several types of quantum dots depending on their uses. 
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They can be customized according to their uses and applications. They can differ in their 
structure, coating, size, diameter, surface charge, exposure time and the environment they 
are used in. These differences in manufacturing and use determine their stability which in 
turn determine the toxic effect of QDs in living organisms. Stable QDs are more resistant 
to photo-oxidation and remain intact for longer periods of time. Photo-oxidation is most 
likely to occur in unstable QDs and release the components of their cores, shells and 
coating resulting in cadmium related cytotoxicity to cells.12 Unmodified “Naked" QD 
cores are known to produce reactive oxygen species which could be detrimental to 
organisms.6 The induced reactive oxygen species could result in damage to biological 
membranes including plasma membranes and mitochondrial membranes.7  
Due to multiple compositions and uses of QDs, their negative effect on biological 
systems is under intense study especially the toxicity of coating materials. Several QDs 
can be customized in terms of its shell and coating depending on their use, so it is very 
necessary to investigate the toxic effect on organisms. The proper surface coatings can 
reduce their toxic effect on organisms. Kim and colleagues investigated the effect of two 
differently coated QDs, one with 3 mercaptopropionic acid and another with tri-n-
octylphosphine oxide (TOPO) in Daphnia magna. The experiment showed that the 
TOPO coated QDs caused a decrease in survival rate of Daphnia magna when treated 
with higher concentrations (100 µg/L) and 3 mercaptopropionic acid coated QDs 
treatment did not show any changes in survival rate across all the treatment 
concentrations.12 One study showed that the CdSe QDs treated neuroblastoma cells 
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caused cell death via a cadmium-induced mitochondrial apoptosis pathway due to 
formation of reactive oxygen species. 13  
 In another study, toxicity of QDs coated with polyethylene glycol (PEG) in 
different conditions were tested in zebrafish.14 Zebrafish were treated with both 
oxidatively degraded and non-degraded PEG-coated QDs for 48 hours. The result showed 
that both degraded and non-degraded QDs had increased effect in death of zebrafish. 
However, the degraded QDs produced a severe effect when tested for morphological 
deformities such as pericardial, ocular and yolk sac edema. The weathered or oxidatively 
degraded QDs produced more pronounced morphological disorder even in lower 
concentrations (20 µM). The quantum dots coated with organic-COOH showed decreased 
cell viability at the lower concentration of 20 nM when treated up to 24 hours while the 
QDs coated with PEG showed reduced cell viability at 80 nM treated up to 48 hours in 
murine macrophages cells.15 There are several studies for determining the cytotoxic effect 
of QDs on cells but the doses used varies from one study to another. Similarly, studies 
have shown that QDs with amphiphilic or protein coatings or ZnSe or ZnS shell are less 
cytotoxic.16  
Similarly, the size of QDs affects their distribution and retention time in vivo. 
QDs’ coating diameter determine the fate of their accumulation or excretion. QDs are 
excreted via urine if the hydrodynamic diameter is less than 5.5 nm. If the diameter is 
bigger than 5.5 nm, there is a chance that these QDs are deposited in liver.17 Also, the 
same study determined that the increasing hydrodynamic diameter increases blood half-
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life. Another study reported that the smaller sized QDs accumulated in liver within 1 hour 
of treatment and later accumulated in liver (15-80 days exposure) and the large QDs 
accumulated in spleen.18 Similar studies done with PEG chains of different length which 
resulted in different hydrodynamic radii, showed that the increase in PEG length 
increased the retention time of QDs in liver.19  
 Surface charge of the QDs also plays an important role in determining the toxicity 
of QDs. Some research has shown that negatively charged QDs are less toxic than 
positively charged QDs. Some biological applications of QDs requires the use of 
positively charged QDs such as in the SiRNA delivery process.11 Quantum dots with 
negatively charged coatings PEG-COOH or positively charge coating PEG-NH2 caused 
severe coagulation and pulmonary thrombosis at the highest dose.20 Another study done 
using similar (PEG-COOH and PEG- NH2) QDs showed that the cytotoxic effect starts to 
appear when treated with doses of 20 nM after 24 hours of exposure.21 A similar study 
showed that coating of QDs determines the subcellular localization of QDs. PEG-NH2 
coated QDs were localized in lysosomes and mitochondria while the non-functionalized 
PEG coated QDs were distributed evenly throughout the cells.15 
  In addition to the structures of coating, the stability of QDs also depend upon the 
environment of their use. Decreased growth rate was observed in Gram-positive Bacillus 
subtilis and Gram-negative Escherichia coli when treated with QDs dissolved in 
solutions weathered in different pH values. The toxic effect was due to the degradation 
and release of their coating, shell and core materials.22 Kim et. al., (2010) exposed QDs 
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coated with TOPO and 3 mercaptopropionic acid to different forms of light such as white 
fluorescence light with or without UV-B for two days. The Daphnia magna exposed to 
TOPO-QDs exposed to UV-B for 2 days showed a significant rise in production of 
reactive oxygen species (ROS). In another experiment, the ability of QDs to withstand 
the intracellular conditions was determined by treating kidney epithelial cells with QDs. 
The result showed that the structure of QDs were not intact and leaked the cadmium out 
of its core. The acidic and oxidative environment of the lysosome could be responsible 
for the breakdown of QDs. Studies have shown that hypochlorous acid and hydrogen 
peroxide degrade the QDs’ polymer coating, resulting in the release of core 
components.22  
Toxicity can also be affected by the exposure time. In vivo studies have shown 
that the QDs can remain in mice up to two years and in some tissues up to 4 years inside 
a body of an organism. When these are accumulated in vivo these also show the blue shift 
in fluorescence. The blue shift is due to the loss of cadmium and selenium ions from QDs 
which imply that the QDs used are being degraded.23 
Mechanism Behind Negative Effect 
The mechanism of the negative effect of QDs on cells is not fully understood but 
the evidence has shown that cadmium binds and deactivates thiol (sulfhydryl) groups on 
iron-sulfur proteins that are essential for proper cellular and mitochondrial function.24 
One way to monitor the effects of QDs on living organisms is studying their effect on the 
subcellular organelle, the mitochondrion, as it is considered the powerhouse of cells due 
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to its capability of producing energy in the form of ATP which is required for proper 
functioning of cells. 
Mitochondria 
Most eukaryotic cells consist of these subcellular organelles, mitochondria that 
are approximately 10 μm in size. The number of mitochondria present in cells depends 
upon their metabolic capabilities. They consist of two membranes, outer and inner 
membranes, with an intermembrane space in between (Figure 3). The outer membrane is 
permeable and the inner membrane is highly selective compared to the outer membrane 
and only allows some substances to pass depending on the transport system. The inner 
membrane surface area is large due to numerous foldings called cristae. Inside the inner 
membrane is a compartment filled with different enzymes known as the matrix. The 
double membrane structure plays an important role in ATP synthesis and in apoptotic 
signaling pathways. In the inner membrane, the mitochondrial electron transport chain is 
located and ATP synthesis occurs by the process of oxidative phosphorylation. 
Mitochondria are also responsible for the metabolism of fats and proteins and the 
removal of toxic ammonia via the urea cycle and for signaling apoptosis or programmed 
cell death. The proper functioning of mitochondria is necessary for healthy and active 
cells and tissues. Studies have shown that mitochondrial dysfunction may be tied to 
various metabolic and degenerative diseases such as Parkinson’s, atherosclerosis, cancer, 





Figure 3: A mitochondrion showing inner membrane, outer membrane, intermembrane 
space, matrix and cristae. 26 
 
ATP Synthesis 
The majority of ATP required for proper functioning of cells is produced by the 
process of oxidative phosphorylation which includes functions of the electron transport 
chain and F0F1 ATP synthase located in mitochondria. The inner membrane of 
mitochondria consists of four enzyme complexes which are coupled with the enzyme 
complex necessary for ATP synthesis, the F0F1 ATP synthase by a proton motive force. 
The four complexes, complex I (NADH: ubiquinone oxidoreductase), complex II 
(Succinate: ubiquinone oxidoreductase), complex III (Ubiquinone: cytochrome c 
oxidoreductase) and complex IV (cytochrome c oxidase) use several oxidation-reduction 
reactions to harvest electrons from the substrates nicotinamide adenine dinucleotide 
(NADH) and succinate. The harvested electrons are used to reduce the final electron 
acceptor molecular oxygen to water and create a proton gradient. Electrons flow from 
complex I and II (lower reduction potential) to complex III and IV (higher reduction 
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potential). The energy produced from oxidizing substrates is used in pumping protons 
across the inner membrane to the intermembrane space, which results in a proton gradient 
and an electrochemical potential across the inner mitochondrial membrane known as the 
mitochondrial membrane potential.25 In the electron transport chain, the electron from 
complex I or II (NADH or succinate) is transferred to the oxidized form of coenzyme Q 
or ubiquinone resulting, in reduction of coenzyme Q. The reduced form of coenzyme Q is 
called ubquinol, which migrates towards complex III. During this process, complex I is 
able to pump protons towards the intermembrance space. At complex III, ubquinol is 
oxidized again, one electron at a time, and the electrons within the membrane are 
transferred to cytochrome c. From cytochrome c, the electrons are transported to complex 
IV. In complex IV, electrons are transferred to molecular oxygen, generating 2 moles of 
water per mole of oxygen. In addition, complex IV also drives protons across the 
membrane creating a proton gradient. The proton gradient is used by F0F1 ATP synthase 
to produce ATP from ADP and phosphate ions. During ATP synthesis, the created proton 
motive force activates the catalyst to drive the reaction between ADP and phosphate ions 
to produce ATP. In this way, active healthy mitochondria are able to use oxygen, form 
water, and maintain the ATP levels in cells through oxydative phosphorylation (Figure 
4). However, during this process, reactive oxygen species are produced as a by-product of 




Figure 4: Electron transport chain and F0F1 ATPase showing oxidative phosphorylation 
and ROS production.27 
 
ROS Production 
The mitochondrial electron transport plays an important role in producing ATP 
which is very essential for life. However, during the process a small amount of electrons 
leak and react with oxygen which results in the formation of reactive oxygen species 
(ROS). The first ROS produced by mitochondria is superoxide anion radical. In the 
electron transport chain (ETC) oxygen is reduced to water through a four electron 
reduction on the surface of complex IV. However, some oxygen is converted to 
superoxide by a one-electron reaction with ubisemiquinone. This is converted into more 
stable hydrogen peroxide (H2O2) due to the action of Mn-superoxide dismutase (SOD) 
present in the matrix of mitochondria. The converted H2O2 can be removed by the 
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antioxidant system comprised of catalase and glutathione peroxidase. In addition, H2O2 
produced in mitochondria also acts as a signaling molecule in the cytosol affecting 
multiple networks such as cell cycle and stress response. If there is an excessive amount 
of H2O2 production due to excessive stress on cells, the antioxidant system of cells may 
not work efficiently to remove it. As a result, H2O2 may generate hydroxyl radical (OH·), 
which is very reactive and is responsible for damaging any molecule it comes into contact 
with.25 Hence the measure of H2O2 produced in cells can be used as a tool for measuring 
the oxidative stress caused by ROS.  
Since mitochondria are very important organelles for the well-being of cells and 
are responsible for the generation of power for proper functioning of cells, studying the 
effects of QDs on this organelle is an effective way to monitor the toxicity of QDs in 
living organisms. The well-being of cells results in proper functioning of tissues and 
proper functioning of tissues results in proper functioning of organs, which in turn results 
in the well-being of an organism. Previous studies in the Thomas lab have shown that the 
mitochondrial functions are negatively affected after treating cells with QDs for 24 
hours.27 In this experiment, we are treating mouse liver cells with three different 




Liver Cells as Models for Quantum Dots Toxicity Studies 
Biodistribution in vivo studies in Sprague-Dawley rats showed that QDs are 
initially targeted to liver and spleen.28 The core metal of QDs, Cd was present in 0.92 µg 
Cd g-1 after 24 hours of injection and 1.69 µg Cd g-1 after 30 days of injection.28 Since 
liver is the major target organ for QDs, liver cell culture models for the safety assessment 
of QDs would be relevant and applicable. The biological model used should be able to 
produce a reliable prediction when eventually used in in vivo systems. The measurement 
of toxicity in in vitro cultured liver cells would be comparable to the effect of quantum 
dots in liver. The liver is one organ which breaks down and metabolizes the toxins from 
all parts of the body and excretes them as harmless by-products into the bile, the intestine 
and feces. When using quantum dots for biological imaging or any other medical 
purposes, QDs will probably be routed to the liver. Thus the cytotoxicity assays done in 







METHODS AND MATERIALS 
In this experiment, Hepa-V cells lines were obtained and maintained in the 
laboratory. A total of four assays were conducted in this study. In the first two assays, 
cell viability assay and ATP luminescence assay, cells were plated in a 96 well plate, and 
in another two assays, mitochondrial membrane potential assay and reactive oxygen 
species (ROS) assay, cells were plated in a 24 well plate. The number of cells plated were 
5000 cells/100 μL for 96 well plate assay and 105 cells/mL for 24 well plate assay. The 
details of the procedures are listed below.  
 
Cell Culture and Passage 
The Hepa-V hepatocyte cell line was obtained from collaborators at the 
University of Washington. The media for cell growth was prepared by adding 50 mL of 
Nu-serum and 10 mL of 100 U/mL streptomycin in 500 mL of Dulbecco’s Modified 
Eagle Medium (DMEM)/F12 medium. The cells were grown in the prepared growth 
medium at 37 °C in a 95% air and 5% CO2 humidified atmosphere in a 25 cm
2 tissue 
culture flask. The cell line was maintained by passing cells once or twice a week. For the 
passing of cells, the older media was removed and cells were washed with 3 mL of 
phosphate buffered saline (PBS) at pH 7.4. After washing, cells were treated with 1.5 mL 
of 0.05% trypsin dissolved in PBS for two minutes at 37°C in a 95% air and 5% CO2 
humidified atmosphere. The treatment of cells with trypsin detached cells from the 
bottom of the flask. After cells were detached from the bottom 5 mL of media was added 
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to stop the activity of trypsin. The mixture of media and trypsin was then transferred to a 
sterile conical tube and centrifuged at 800 rpm for 6 minutes. The trypsin and media 
mixture was aspirated and the pellet of cells in the bottom of a conical tube was re-
suspended in 5 mL fresh media. 1 mL of resuspended cells in fresh media was taken and 
transferred to a sterile flask and 4 mL of fresh media was added. The new flask was 
incubated at 37 °C in a 95% air and 5% CO2 humidified atmosphere. This process of 
transferring cells from one flask to the other is known as passage of cells. Cells from 
passage 1 through 9 were used in this study.8, 29  
From the remaining resuspended cells in 5 mL of fresh media, 100 μL of the cell 
suspension was removed and diluted with 200 μL of water, then 10 μL of that solution 
was added to a hemocytometer and the number of viable cells was counted under the 
inverted microscope. 
 
Counting Cells using a Hemocytometer and Plating Cells for Experiments 
A hemocytometer microscope slide has etching or markings that consists of four 
large clear squares on the corners divided into 16 smaller squares each. The detail on the 
hemocytometer can be seen in figure 5. After 10 μL of diluted cell sample was applied to 
the hemocytometer, a coverslip was placed on the cells. Cells in each of those four 
squares including one large central square in the middle were counted. The average 
number of viable cells counted under an inverted microscope on these five large squares 
were calculated by dividing the total number of cells counted by 5. The total number of 
cells present in each mL of media was determined by using the following formula: 
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average number of cells counted in 5 squares of the hemocytometer X dilution factor X 
104. After the number of cells per mL was determined, the cells were diluted using cell 
growth media to 5000 cells/ 100 μL for a 96 well plate assay and 105 cells/ mL for a 24 
well plate assay.  
 




Treatment of Cells with Quantum Dots 
TOPO-PMAT QDs were also provided by our collaborators at the University of 
Washington. QDs were stored in microfuge tubes wrapped in parafilm at room 
temperature inside a black conical tube to protect them from light. Cells were cultured in 
96 or 24 well plates for 24 hours, and then treated with three different concentrations of 
QDs (2, 20 and 40 nM) for 24 hours at 37 °C and 5% carbon dioxide.8 The stock solution 
of 900 nM of QDs in PBS was sterilized with a 0.22 μm filter attached to a sterile 
syringe. The sterilized QDs in PBS were diluted using an appropriate volume of DMEM 
medium with 10 % Nu-serum and 100 U/mL streptomycin. For 96 well plate assays, 100 
μL of final volume was maintained and for 24 well plate assays the final volume of 400 
μL was maintained for all three concentration of treatments. Following the 24-hour QDs 
treatment, the four assays were conducted.  
 
Cell Viability Assay 
The cell viability assay was used to determine the ability of cells to maintain or 
recover viability. It is an enzyme-based method that works by determining the 
mitochondrial dehydrogenase activity in the living cells. In this experiment we used a 
water-soluble tetrazolium salt, [2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-
disulfophenyl)-2H-tetrazolium, monosodium salt] (WST-8, Dojindo Inc.), which is a 
modified MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay, to 
monitor the mitochondrial dehydrogenase activity of cells. WST-8 salts receive two 
electrons from viable cell mitochondrial dehydrogenases to generate an orange, yellow or 
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purple formazan crystal. The assay was used to monitor the effect of QDs on cell 
proliferation compared to untreated cells. In this assay, 5000 cells per 100 μL were plated 
and grown for two days or until cells were 80% confluent and treated with three different 
concentrations of QDs. On the day of assay, older media and QD treatment was aspirated 
and replaced with 90 μL of fresh media and 10 μL of WST-8 salt. One well was added 
with 90 μL of 40 nM QDs only and 10 μL of WST-8 salt which gave the background 
absorbance of QDs only. Then the cells were incubated for 4 hours at 37 °C and 5% 
carbon dioxide. After incubating for 4 hours, the contents of each well was transferred to 
unused wells and absorbance was read at 450 nm using a Synergy II plate reader. The 
background absorbance reading of QDs was subtracted from the absorbance value of 
QDs treated wells. The negative control used in this experiment was 20% dimethyl 
sulfoxide (DMSO). The working mechanism of WST-8 in determining cell viability can 





Figure 6: WST-8 reduction reaction in presence and absence of dehydrogenase. WST-8 is 
reduced by the dehydrogenase activity of cells into WST-8 formazan which is absorbed 
at 450 nm. Dehydrogenase is only produced by healthy cells and is proportional to the 
number of healthy cells. In absence or low amount of dehydrogenase, lower amount of 
WST-8 is converted to WST-8 formazan and absorbance at 450 nm decreases.  
 
Adenosine Triphosphate (ATP) Luminescence Assay 
Cells consume energy during their regular cellular processes of growth and 
metabolism. The required cellular energy form for these processes is adenosine 
triphosphate (ATP). When cells are treated with QDs, the amount of ATP produced by 
cells may be affected. The ATP luminescence assay was used to determine the amount of 
ATP in QD-treated cells compared to control cells. Cells were plated and treated 
similarly to the cell viability assay except a 96 well white luminescence plate was used. 
After the 24 hour QD treatment in 96 well plates, cells were washed with PBS buffer and 












































treatment of cells with Triton-X 100 solubilized the cell membranes to release 
cytoplasmic ATP. Then, 100 μL of assay solution (250 mM glycylglycin buffer, pH of 
7.3, 2 mM EGTA, 2 mM MgCl2˙6H2O, 7.5 mM dithiothreitol, 15 μM luciferin and 10 μg/ 
mL luciferase) was added to the each well and the luminescence intensity of the reaction 
was measured immediately using a Synergy II luminescent plate reader with a plugged 
hole in the excitation filter wheel and a hole in the emission filter wheel. The ATP 
produced by cells in each well with the treatment of QDs was compared to the ATP 
produced by control cells and recorded as percent of control.30 The amount of ATP 
produced in control cells was determined by the ATP standard curve with concentrations 
ranging from 10 -6 to 10 -9 nM by monitoring luminescence with a Synergy II plate reader. 
For positive control (lower amount of ATP production), cells were treated with 10 μM 
antimycin A for 6 hours and luminescence was quantified. 1 μL of 1 mM of Antimycin A 
stock solution prepared in 1:1 PBS and ethanol was taken and added to positive control 
wells resulting in final concentration 10 μM of antimycin A and 0.5% of ethanol in each 
positive control well. The reaction of ATP with luciferin in the presence of luciferase is 






Figure 7: Reaction of luciferin and ATP in presence of luciferase.  
 
Flow Cytometry 
A flow cytometer (Bio-Rad S3e cell sorter) was used to collect data for two 
assays: the mitochondrial membrane potential assay and the reactive oxygen species 
(ROS) assay. Both of the assays used fluorescent dyes. The dye, JC- 10 was used for 
mitochondrial membrane potential assay. JC-10 dye exists as monomers in the cytoplasm 
and monomers aggregate to form J-aggregates inside the mitochondria in cells which was 
measured in two different excitation/ emission spectra in the flow cytometer. The filter 1 
(FL1) channel measures the fluorochrome emission between 525 ± 30 nm and the filter 2 
(FL2) channel measures fluorochrome emission between 586 ± 25 nm.  In this case, the 
JC-10 dye is the fluorochrome. The JC-10 dye was examined for median fluorescence 
intensities using both of these channels and a fluorescence intensity ratio (FL2/FL1) was 
calculated. For the ROS assay only the median fluorescence intensity at FL1 was 




number of events refers to the number of single cells analyzed in the experiment. The 
collected number of events were analyzed by using a software program called FlowJo 
(V.10.1). FlowJo allows users to choose a population of cells to be analyzed, a process 
known as “Gating”. It is a process by which dead cells and debris that have been counted 
as events in the experiment are separated from the actual population of live cells being 
analyzed.  
Mitochondrial Membrane Potential Assay 
The mitochondrial membrane potential is related to the cell’s ability to make 
ATP. To monitor the effect of QDs on mitochondrial membrane potential, a lipophilic 
cationic dye JC-10 (Enzo Life Sciences) was used and analyzed using a flow cytometer in 
the Biology Department at CWU. Cells were plated in 24 well plates at 1 X 10 5 cells per 
mL and incubated until cells were 85 % confluent. After treating cells with QDs for 24 
hours, QDs and media were aspirated and cells were washed with 200 μL of warm PBS. 
6.7 μL of 1.5 mM JC-10 dye dissolved in 1:1 dimethyl sulfoxide (DMSO) and 20 mM 4-
(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer in Hank’s Balanced 
Salt Solution (HBSS) with final pH of 7.3 with 0.02% pluronic F-127 and 493.3 μL of 
media was added to each well making the final concentration of dye to be 20 μM. The 
final concentration of DMSO in cells was maintained to be 0.67%. After the treatment of 
cells with JC-10, cells were incubated for 30 minutes at 37 °C in a 95% air and 5% CO2 
humidified atmosphere.31 After the incubation, cells were washed with warm PBS and 
200 μL of 0.05% trypsin was added. Cells were detached from the culture flasks and 500 
μL of media was added to stop the activity of trypsin. Cells were transferred to a 5 mL 
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microfuge tube and centrifuged for 6 minutes at 800 rpm. Then the media and trypsin mix 
was aspirated and cells were re-suspended in HHBS buffer. Then the cell samples were 
analyzed using flow cytometry. QDs exposed cells treated with JC-10 produces green 
emission (JC-10 monomers) and orange emission (JC-10 aggregates) indicating low and 
high mitochondrial membrane potential, respectively.  Fluorescence intensities from 
channels FL1 and FL2 were measured in cells by flow cytometry, the median 
fluorescence intensity was analyzed and determined using FlowJo. The ratio of 
fluorescence intensities at FL2/FL1 was calculated. For a positive control, cells were 
treated with 5 μM of carbonyl cyanide-4-(trifluoromethoxy) phenylhydrazone (FCCP) in 
ethanol for 10 minutes and then treated with JC-10 dye.32 The 5 μM of FCCP was 
prepared from the stock solution of 1 mM FCCP dissolved in ethanol. 5 mL of the stock 
solution was added to 495 μL of media resulting in final concentration of 5 μM FCCP 
and 1.1% of ethanol. 
 
Growing Cells for Fluorescence Microscopy 
For the fluorescence microscopy experiment Hepa-V cells were grown on a cover 
slip. The 22 mm square coverslip was sterilized by spraying with 70 % ethanol and then 
with flame. The coverslip was placed in a 60 X 15 mm petri dish. 1 mL of cells 
resuspendend in 4 mL of DMEM/F12 was added to the petri dish. The cells were allowed 
to grow for 48 hours in 37 °C in a 95% air and 5% CO2 humidified atmosphere. After 48 
hours, media from the petri dish was removed and added with 3.0 mM JC-10 dye 
dissolved in 1:1 DMSO and 20 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
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(HEPES) buffer in Hank’s Balanced Salt Solution (HBSS) with final pH of 7.3 with 
0.02% pluronic F-127 and DMEM/F12. Then the petri dish was incubated for 1 hour. 
Then, the petri dish contents were aspirated and the coverslip was washed with 5 mL of 
PBS twice. After washing, the coverslip was taken out of the petri dish using tweezers 
and placed inverted on a microscope glass slide. The coverslip was placed on the glass 
slide in such a way that the side on which cells were growing faced the glass slide. Two 
drops of PBS were added to the glass slide before placing the coverslip. Excess PBS after 
placing the coverslip was removed using a Kim wipe. After placing the coverslip in the 
desired position, it was sealed using clear nail polish on all 4 sides of the coverslip. After 
the nail polish dried, the whole slide was cleaned with lens cleaner and read under a 
fluorescence microscope and images were taken.33  
 
Intracellular ROS Assay 
The intracellular reactive oxygen species (ROS) production was measured using a 
fluorescent dye called CellRox green (Invitrogen, Inc.) and flow cytometry. Cells were 
plated at 100,000 cells / mL in 24 well plate and incubated until 85% confluent then cells 
were treated with QDs for 24 hours. On the day of the assay, the plated cells were 
aspirated and 498 μL of fresh media was added.  2 μL of 250 μM of CellRox green dye 
was then added to the cell plated wells and incubated for 45 minutes protected from the 
light giving a final concentration of CellRox green of 1 μM. After the incubation, the 
media was removed and cells were removed from the plate with trypsin and resuspended 
in FACS (fluorescence activated cell sorting) buffer which consists of 1% BSA and 0.1% 
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sodium azide buffer. For a positive control, 498 μL of 300 μM tert-butyl hydroperoxide 
(TBHP) diluted in media was added to the cells and incubated for 45 minutes.34 TBHP 
reacts with ferrous iron to produce hydroxyl radical via a process of Fenton chemistry 
where the iron is oxidized by the TBHP (Figure 8). 
 
             Figure 8: TBHP reaction with ferrous ion to produce hydroxyl radical, •OH. 
 
Statistics 
For each experiment, the data collected was averaged and standard deviation (Cell 
viability and ATP assay) or range (Mitochondrial membrane potential and ROS assay) 
were calculated. Data collected for each experiment was analyzed for statistical 
significance by using one-way ANOVA and the significance was set to P ≤ 0.05. All the 
statistical analyses were done by using Microsoft Excel version 2013. The replicates for 








 A cell viability assay was used to determine the effect of QDs on cell proliferation 
and the cytotoxic effects to cells that would eventually lead to cell death. Cell viability 
was evaluated by using a modified water soluble MTT assay.  In this method, water 
soluble tetrazolium salt is reduced due to the activity of mitochondrial dehydrogenases. 
The measurement of activity of mitochondrial dehydrogenase produced by the active and 
healthy cells helps to determine the cell viability. Hepa-V cells showed a trend of 
decreased mitochondrial dehydrogenase activity when treated with 2 nM, 20 nM and 40 
nM QDs. The trend showed that the cells treated with 2 nM, 20 nM and 40 nM QDs 
appear to have 21.5%, 20.9% and 13.8% decreased cell viability respectively (Figure 9).  
However, the decrease in dehydrogenase activity was not statistically significant (P>0.05) 
compared to control cells analyzed by one-way ANOVA. The positive control used in 
this experiment (20% DMSO) showed 73% decrease in cell viability. DMSO at 






Figure 9: Cell viability in liver cells after 24-hr exposure to QDs. Liver cell 
mitochondrial dehydrogenase activity measured by the water soluble MTT assay (WST-
8). Analysis by one-way ANOVA (p=0.08, n=6), indicates no significant effect of QDs 
on metabolic cell death.  Positive control cells were treated with 20 % DMSO for 1 hr. 
 
 
ATP Content in Cells 
Adenosine 5'- triphosphate (ATP) is very crucial in biological systems for 
exchanging energy. It is produced and present in all metabolically active cells as an 
immediate free energy donor. The production of ATP in cells denotes the cellular 
integrity as cells require ATP for proper functioning. An ATP luminescence assay was 
used to determine the quantity of ATP produced by Hepa-V cells. In this method, the 
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luciferase to produce light. The result showed that there was no significant decrease in 
ATP produced by cells when treated with different concentrations of QDs (p>0.05, one-
way ANOVA). There was a trend of 2%, 2% and 14% decrease in ATP production by 
cells when treated with 2 nM, 20 nM and 40 nM QDs, respectively (Figure 10). However, 
it was not statistically significant.  
 
Figure 10: ATP production in liver cells after 24-hr exposure to QDs. ATP production of 
liver cells was determined by the Luciferase/luciferin luminescence assay.  Control 
consists 1.5% Triton-X 100. Positive control cells were treated with 10 µM Antimycin A 
for 6 hours. Analysis by one-way ANOVA (P= 0.17, n=6) indicates no significant effect 
of QDs on ATP production of cells. ATP values of the control cells ranged between 42 
nM and 88 nM per 5000 cells. 
 
The positive control used in this experiment was 10 µM antimycin A which 
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with electron flow from complex III to cytochrome C. In the presence of antimycin A 
cytochrome c remains oxidized, eventually stopping the process of ATP production. 
  
Mitochondrial Membrane Potential Assay using JC-10 
 Mitochondria are considered to be the power house of cells since they generate 
ATP. The change in mitochondrial membrane potential (Δψm) indicates the capacity of 
mitochondria to generate ATP and maintain cell health. In this experiment, a cationic 
lipophilic dye (JC-10) was used in order to determine Δψm in cells. JC-10 is a 
mitochondrial membrane permeable dye which can exist in its monomeric and J- 
aggregate forms depending on the Δψm. As mitochondria become more polarized 
(increase Δψm), more JC-10 enters mitochondria and JC-10 starts forming J- aggregates 
shifting the fluorescence emission from 530 nm to 590 nm, fluorescing red. In healthy 
cells, the amount of J- aggregate is always equal to or higher than that of the monomer. 
The result from fluorescence microscopy showed that the JC-10 dye used for the 
mitochondrial membrane potential assay appears to fluoresce both green (FL1) and red 





Figure 11: Fluorescence microscopy images of localization of JC-10 dye in Hepa-V cells. 
Cells were grown on a coverslip for 48 hours and treated with JC-10 dye for 45 minutes. 
Separate images were taken using different fluorescence filters for cells (panel A: ex/em: 
488/530 nm and Panel B: ex/em: 488/590 nm) 
 
As the mitochondrial membrane potential decreases, the amount of fluorescence at FL2 
decreases and hence the ratio of FL2/ FL1.  
 A Δψm assay was performed using JC-10 dye and cells were analyzed using flow 
cytometry. The JC-10 dye forms J- aggregates which fluoresces with emission at 590 nm 
(FL2). In healthy cells with a high mitochondrial membrane potential, the accumulation 
of J- aggregates is equal to or higher than its monomeric form. The results showed that 
the ratio of FL2/ FL1 decreased as the concentration of QDs increased. The ratio of FL2/ 
FL1 is similar when compared between the control cells and cells treated with 2 nM QDs. 
The fluorescence intensity FL2/ FL1 ratio of cells treated with 20 nM and 40 nM 










Figure 12: Mitochondrial membrane potential in liver cells after 24-hr exposure to QDs. 
JC-10 dye (20 µM) was added to Hepa-V liver cells and incubated for 30 min. Postive 
control cells were treated with FCCP (5 µM) and incubated for 10 min. The median 
fluorescence intensities for both J-aggregates and monomeric forms of JC-10 were 
measured, at Ex/Em = 488/590 nm and 488/525 nm with flow cytometry and their ratio 
was calculated (FL2/FL1). Analysis by one-Way ANOVA (P= 0.00017, n=2) indicates 
significant effect of QDs on Δψm. Two values were averaged and the error bar represents 
the range of those values. 
 
The decrease in FL2/ FL1 ratio showed that the amount of J- aggregates 
accumulated in mitochondria of cells decreased as the concentration of QDs increased in 
the cells. The decrease in amount of J- aggregates suggested that the mitochondrial 
membrane potential of cells was decreasing with increased concentration of QDs in cells. 
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denoted by decreased FL2/ FL1 ratio. FCCP uncouples the mitochondria as a result of 
which mitochondrial membrane potential decreases.32  
Reactive Oxygen Species (ROS) Production in Cells 
Cells produce reactive oxygen species (ROS) during the process of formation of 
ATP through oxidative phosphorylation. In normal conditions, cells have their own 
antioxidant mechanism to remove ROS. However, under stress cells may be making more 
ROS than they remove.  The presence of ROS in cells is an indicator of stress due to 
exposure to chemicals such as QDs.  In this experiment the ROS produced by cells when 
treated with QDs were measured by the fluorescence intensity of CellRox green dye 
which fluoresces brightly in the presence of reactive oxygen species and is detected using 
the FL1 filter in the flow cytometer. Due to limited amount of QDs, the experiment was 
performed two times only. The data for these experiments is questionable because the 
flow cytometer was clogged on the day of the experiment and cells were stored in 
refrigerator for more than two hours before analyzing in flow cytometer. We were unable 
to combine these two experiments together and do a statistical analysis on it.  
The first experiment (trial 1) showed the decreased trend in production of ROS 
when treated with QDs compared to control cells. It showed that the production of ROS 
in cells treated with 20 nM and 40 nM had a decreased trend as compared to control cells 
but increased trend as compared to cells treated with 2 nM QDs. However, the positive 
control in the experiment also showed a decrease in ROS production. For the positive 
control, cells were treated with tertiary butyl hydrogen peroxide (TBHP), a known ROS 
producer with an expected result of increasing ROS (Figure 13, Panel A). 
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The second experiment (trial 2) showed similar trends. The production of ROS 
showed a decreased trend in cells treated with QDs as compared to control cells.  The 
production of ROS in cells treated with 20 nM appeared to decrease as compared to 
control cells but appeared to increase as compared to the cells treated with 2 nM and 40 
nM QDs. The positive control also showed an increase in ROS production which was 
expected (Figure 13, Panel B).  
Even though the positive control did not work on the first experiment, the results 
are comparable in both the experiments. The trend of decreased ROS when treated with 2 
nM QDs was similar in both experiments. When treated with 20 nM, QDs production 
ROS decreased as compared to control but increased as compared to 2 nM treatment and 
the trend is similar in both experiments.  When treated with 40 nM QDs, the ROS 
production decreased as compared to control in both experiments. However, the ROS 
production with 40 nM QDs treatment was equal to ROS production when treated with 

























Figure 13: Production of reactive oxygen species (ROS) in liver cells after 24-hr 
exposure to QDs. CellRox green dye (1 µM) was added to Hepa-V liver cells and 
incubated for 45 min. Positive control cells were treated with 300 µM tertiary butyl 
hydrogen peroxide (TBHP) and incubated for 45 min.  The median fluorescence 
intensities for CellRox green dye was measured at Ex/Em = 488/530 nm with flow 
cytometry (FL1 median fluorescence intensity). Panel A contains the data from Trial 1 







































































Comparison of Fluorescence of QDs and JC-10 Dye 
The quantum dots used in these experiments have a maximum fluorescence 
emission at 620 nm which is measured with the FL3 filter on the flow cytometer.8 
However, the emission spectrum of QDs showed some overlap in emission at wavelength 
590 ± 25 nm, which can be measured by using FL2 in the flow cytometer. The dye used 
in these experiments fluoresced and were analyzed and detected through FL1 or FL2 in 
flow cytometer. To show that the median fluorescence intensity of dyes used such as JC-
10 and fluorescence of QDs did not overlap with each other, Hepa-V cells were treated 
with 20 nM of QDs and analyzed with flow cytometry using filters FL2 and FL3. The 
median intensity recorded for QDs at FL2 was 277 and at FL3 was 10,337 (Figure 14, 
Panel A left and right). We compared these median fluorescence intensities to the median 
fluorescence intensities of the cells treated only with JC- 10 dye. The fluorescence 







Figure 14: Median fluorescence intensity of Quantum dots (Panel A) and JC-10 (Panel B) 
in FL2 (left) and FL3 (Right). Hepa- V cells were treated with 20 nM QDs for 24 hours 
and analyzed using flow cytometry. The median fluorescence intensity of QDs in both 
FL2 (panel A, left) and FL3 (Panel A, right) is shown. The median fluorescence intensity 
of JC-10 treated cells in both FL2 (panel B, left) and FL3 (panel B, right) is shown.  
 
The median fluorescence intensity of QDs in cells is similar to that of control cells 
with JC-10 stain only. Thus, the result showed that the background of QDs was not 





remarkably higher when detected through FL3 more than 37-fold increment as compared 

























 The TOPO-PMAT QDs used in this study are the group of QDs that would be 
used in imaging and medical purposes due to their extraordinary properties. These QDs 
are highly soluble and stable in aqueous environments.8 The carboxylic functional group 
attached to the coating makes these QDs applicable for ligand attachment which would 
be very helpful in medical applications. 
The cells used in this study are mouse liver cells (Hepa-V) and represent the cells 
of the organ which TOPO-PMAT may encounter if used for medical purposes. QDs with 
a bigger diameter than 5.5 nm are most likely deposited in the liver.17 The diameter of 
TOPO-PMAT QDs used in this experiment is 12.7±0.5 nm8, so these are most likely to 
be deposited in liver. Also as the size increases, the retention time of QDs in liver 
increases.19 Since the liver is the target organ for the QDs of this size, the experiment 
performed in liver cells is representative of the effect that these QDs may have in liver 
when used in vivo.  
The analysis of cells using flow cytometry after treating with QDs for 24 hours 
showed that the QDs were present inside the cells and that the majority of the QDs’ 
fluorescence was detected through channel (FL3) (Figure 14, panel A). The finding was 
similar to previous work done in the Thomas research lab in Hepa-1c1c7 (CR-17) cells.27 
Hepa-1c1c7 cells are also mouse liver cells but with enhanced glutathione levels. The 
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result showed that Hepa-1c1c7 cells were able to uptake and internalize the QDs after 4 
hours of treatment.27 Smith et al. (2012) showed that, nearly all HepG2 (human liver 
cells) were able to internalize TOPO-PMAT QDs.36 Similar studies with different cells 
(human macrophages, human kidney cells) confirmed that the QDs were internalized by 
these cells.8 These data showed that TOPO-PMAT QDs can be readily internalized by 
cells when the QDs come in contact with live cells. Hence a thorough study should be 
undertaken before considering the use of these QDs in vivo as they can be readily 
internalized by many different types of cells.  
Our results showed that the QDs did not have any significant effect on cell 
viability of Hepa-V cells. This result is similar to previous studies in human hepatocytes 
cells. Human hepatocytes did not show any decrease in cell viability when treated with 2 
nM to 40 nM TOPO-PMAT QDs over 24-48-hour period.36 Although our experiment did 
not show any significant decrease in cell viability, the treatment of cells with 2 nM, 20 
nM and 40 nM QDs showed a trend of decreased cell viability by 21.5%, 20.9% and 
13.8% respectively. The cell viability decreased by 20% in lower concentration of 
treatment while it decreased by only 13.8% at higher concentration treatment. The 
finding is similar to the McConnachie and colleagues’ cell viability experiment 
conducted in human kidney cells in which the percent of cell viability increased as the 
concentration of TOPO-PMAT QDs increased to 40 nM.8 This can be attributed to the 
activation of metabolic function of cells to make Nicotinamide adenine dinucleotide 
phosphate (NAD(P)H) more available under stress that may have been produced due to 
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exposure to QDs.37 The presence of more NAD(P)H allows cells to remove more ROS 
using glutathione peroxidase for example, which converts hydrogen peroxide to water 
and oxygen.  
Similarly, our results showed that there was not a significant change in ATP 
production when cells were treated with 2 nM, 20 nM and 40 nM of QDs. The ATP 
production showed a decreased trend, by only 2% when treated with 2 nM and 20 nM 
QDs, and by 14% when treated with 40 nM QDs. This trend showed that the amount of 
ATP produced by cells was constant and cells were able to maintain the amount of ATP 
produced. In previous studies it was shown that cells under stress are triggered to produce 
more ATP.38 The level of intracellular ATP increases as a result of induced stress.38 The 
release of ATP is a response of cells to induced stress. When cells were treated with 
different concentrations of QDs, cells were exposed to the stress. It is possible that in 
response to the QDs induced stress, cells started generating intracellular ATP.  The 
intracellular ATP can be generated from glycolysis and other metabolism pathways such 
as the citric acid cycle in order to regulate the normal function of cells. When cells are 
treated with 40 nM of QDs, the ATP production trend decreased compared to control and 
other treatment cells. The stress from higher concentration treatment may have been more 
than the cells could handle as a result of which the ATP concentration decreased as 
compared to the other treatments.  
The energy produced from oxidizing substrates in the electron transport chain is 
used in pumping protons across the inner membrane to the intermembrane space, which 
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results in a proton gradient and an electrochemical potential across the inner 
mitochondrial membrane known as the mitochondrial membrane potential. The proton 
motive force is used to generate ATP through ATP synthase. The measure of 
mitochondrial membrane potential is a sign of healthy and functioning cells. The result 
showed that the mitochondrial membrane potential decreased significantly when treated 
with 20 nM and 40 nM of QDs. Interestingly, mitochondrial membrane potential 
increases slightly when treated with 2 nM QDs. Similar studies on the effect of CdTe 
QDs on mitochondria showed that the mitochondria swell in the presence of QDs. They 
permeablize the mitochondrial inner membrane to H+ and K+ ions. These ions play an 
important role in distribution of charges across the inner mitochondrial membrane. The 
disturbance in this distribution of charges decreases the proton electrochemical gradient. 
This effect increased as the concentration of QDs increases from 50 nM to 50 µM.39 The 
appropriate level of ion concentration is very important for the proper functioning of the 
mitochondria for the energy generation through the proton electrochemical potential 
gradient.  In the presence of QDs the balance of these appropriate ion gradients is 
disturbed and the membrane potential decreases. The decrease in membrane potential 
indicates mitochondrial uncoupling. Uncoupling of mitochondria disrupts the process of 
ATP formation and ROS production.  
A ROS assay was performed using CellRox green dye and the result showed that 
the production of ROS decreases when treated with different concentrations of QDs in 
two experiments. ROS are produced in cells as a by-product of ATP formation through 
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oxidative phosphorylation. Cells have their own antioxidant process to remove these ROS 
through reaction with superoxide dismutase and glutathione peroxidase. However, if cells 
start producing more ROS, the cells’ natural antioxidant system may not be able to 
remove ROS giving rise to the presence of ROS in cells putting cells under oxidative 
stress. So the measurement of ROS when they are exposed to QDs is a way to determine 
the oxidative stress cells are going through.  
The trend in both the experiments showed that ROS production decreased when 
treated with different concentration of QDs. Even though the flow cytometer was not 
functioning and cells had to be stored in the refrigerator for more than two hours before 
analysis, the trend of decreased ROS production in cells treated with QDs were similar in 
both experiments (Figure 13). Similar effects had been shown when cells are treated with 
uncoupling protein such as UCP 3 and UCP 1.39 The presence of these proteins plays a 
role in uncoupling oxidative phosphorylation which reduces the mitochondrial membrane 
potential. We observed a significant decrease in mitochondrial membrane potential in 
cells treated with QDs. When mitochondria started depolarizing and the mitochondrial 
membrane potential decreased in the presence of uncoupling protein UCP 3 an UCP 1, 
the production of ROS was decreased which is in parallel to our findings. In addition, a 
study on the effect of MPA-CdSe/ZnS QDs on plant cells (Sativa cells) showed that cells 
responded to oxidative stress by increasing the antioxidant enzyme systems such as 
superoxide dismutase.40 When cells are put under stress they respond to it by 
upregulating antioxidant enzymes.41 It is possible that when cells were treated with QDs, 
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cells were under stress and upregulated the antioxidant enzyme as a result of which ROS 
production decreased.  
However, other studies showed the increase in ROS in spite of an increase in 
antioxidant enzyme. The study was performed on liver cells of Mus musculus mouse 
(AML 12) treated with 20 µg/mL- 40 µg/mL CdTe QDs for 24 hours, which showed a 
significant increase in ROS.42 The doses used in this experiment were very high 
compared to our experiment. It is possible that at lower doses (2 nM – 40 nM), the 
increased function of antioxidant systems is enough to remove the ROS and when the 
concentration of QDs treatment increases it is difficult for cells to remove ROS in spite of 
upregulation of antioxidant enzymes.  
 The QDs used in this study are composed of a CdSe/ZnS core/shell. Studies have 
shown that CdSe/ZnS QDs treated MCF-7 cells showed the presence of cadmium to be 
low to none when detected by Cd2+ cell assay compared to other QDs such as CdTe QDs. 
Also it was found that CdSe/ZnS QDs were non-toxic in terms of cell viability. In 
addition, the study showed that upon photoxidation CdTe QDs generate oxidative stress 
which was not found in ZnS coated QDs.43 Since the CdSe core of the QDs used in our 
studies were covered with ZnS, it is possible that we observed mild toxicity due to this 
protective shell. The structure of QDs with ZnS may be manufactured in such a way that 
they remain intact for a long period of time and with less leaking of the core component 
cadmium which is associated with toxicity to cells.24 
 The internalization and toxic effects caused by QDs also depends upon the growth 
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medium used in cell culture. Several nanoparticles such as QDs are known to form 
coronas around them as the proteins in the growth media is absorbed by them. This may 
mitigate the effects of QDs in cells.44 The type of protein coronas formed around QDs 
depends upon the protein components added to the media. Studies have shown that the 
use of fetal calf serum (FCS) in media may agglomerate the nanoparticles showing no or 
low toxicity in cells.45 In our study all cells were grown in DMEM/F12 media 
supplemented with 10% Nu-serum which is substituted for the FCS in the medium and 
shows similar growth of cells. Nu-serum may have resulted in agglomeration of QDs 
used in this experiment which may have resulted in no significant effect in cell viability. 
However, a review paper on the formation of protein coronas states that the QDs with 
amphiphilic coatings do not form large protein coronas compared to hydrophilic QDs.44 
The QDs used in our study were amphiphilic QDs which may not have formed the 
coronas and were not involved in mitigating the toxic effect of QDs. Hence, the observed 
result may not be due to the formation of protein coronas around QDs. The QDs used 
may be less toxic due to the presence of ZnS shell, TOPO-PMAT coating and carboxylic 
acid functionalization. The shell and coating acted as a protective layer around the core of 







This study found that the TOPO-PMAT coated CdSe/ZnS QDs did not result in 
significant decrease in cell viability and ATP production. In addition, the result showed 
that these QDs resulted in a decrease in mitochondrial membrane potential which denotes 
uncoupled mitochondria. Although the data may not be reliable due to instrument 
malfunction, we observed a decrease in the production of reactive oxygen species (ROS). 
These results on Hepa-V cells suggest that similar effects may be seen on liver cells if 
used in vivo in humans.  
These results showed that the use of TOPO- PMAT QDs is mildly toxic to cells 
indicated by a trend towards decreasing cell viability, ATP production and a significant 
decrease in mitochondrial membrane potential. At the lower concentration (2 nM), results 
showed minimal effect on cell viability, ATP production and mitochondrial membrane 
potential after a 24-hour treatment or exposure to QDs. This might indicate that it is safe 
to use QDs at lower concentrations for in vivo medical applications. However, caution 
should be applied if using in higher concentrations (20 nM or 40 nM) as the QDs may 
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Figure A1. Cell viability after 24-hr exposure to C60. Liver cell mitochondrial 
dehydrogenase activity measured by the water soluble MTT assay (WST-8).  Analysis by 
1-Way ANOVA (p<0.05, n=6), indicates a significant effect of C60 on metabolic cell 





































Figure A2: ATP production in liver cells after 24-hr exposure to C60.  ATP production of 
liver cells was determined by the Luciferase/luciferin luminescence assay.  Vehicle 
control consists of DMEM and the 7.5% BSA in PBS.  Negative control cells were 
treated with 10 M Antimycin A for 6 hours. (P> 0.05, n=9).  ATP values of the control 
























Figure A3. Mitochondrial membrane potential in liver cells after 24-hr exposure to C60.  
JC-10 dye (20 µM) was added to Hepa-V liver cells and incubated for 30 min.   Negative 
control cells were treated with FCCP (5 µM) and incubated for 10 min.  The median 
fluorescence intensities for both J-aggregates and monomeric forms of JC-10 were 
measured at Ex/Em = 488/590 nm and 488/525 nm with flow cytometry and their ratio 



































SS df MS F P-value F crit 
Between 
Groups 
541.1337196 3 180.3779065 1.846785609 0.174871735 3.15990759 
Within 
Groups 
1758.082964 18 97.67127576    
Total 2299.216683 21         
 




SS df MS F P-value F crit 
Between 
Groups 
35.37440882 4 8.843602204 64.85889198 0.000169741 5.192167773 
Within 
Groups 
0.681757114 5 0.136351423    





SS df MS F P-value F crit 
Between 
Groups 
0.015184438 3 0.005061479 2.594869305 0.082553804 3.127350005 
Within 
Groups 
0.037060867 19 0.001950572    




FLOW CYTOMETRY DOT PLOTS and HISTOGRAMS FOR QDs 
Mitochondrial Membrane Potential Assay 
 
Figure A4: Flow cytometry dot plots and histogram showing gating and median 
fluorescence intensity at FL2 for mitochondrial membrane potential using JC-10 dye. 
A (Top, Bottom): Gating and FL2 intensity of no stain cells, B (Top, Bottom): Gating and 
FL2 intensity of stained cells, C (Top, Bottom): Gating and FL2 intensity of stained cells 
treated with 2 nM QDs, D (Top, Bottom): Gating and FL2 intensity of stained cells 
treated with 20 nM QDs, E(Top, Bottom):Gating and FL2 intensity of stained cells 
treated with 240 nM QDs, F(Top, Bottom):Gating and FL2 intensity of stained cells 
treated with 5 µM FCCP. 
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Reactive oxygen species  
Figure A5: Flow cytometry dot plots and histogram showing gating and median 
fluorescence intensity at FL1 for reactive oxygen species (ROS) assay using CellRox 
green dye. A (Left, Right): Gating and FL1 median intensity of stained cells, B (Left, 
Right): Gating and FL1 intensity of 2 nM, C (Left, Right): Gating and FL1 intensity of 
stained cells treated with 20 nM QDs, D (Left, Right): Gating and FL1 intensity of 
stained cells treated with 40 nM QDs, E (Left, Right): Gating and FL1 intensity of 
stained cells treated with 10 µM of tert. butyl hydrogen peroxide. 
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